Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/1/22 → 08/31/26 |
Funding
- National Inst of Neurological Disorders & Stroke: $10,250.00
NN111- A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
- Eckert, Svetlana (PI)
Project: Research